Literature DB >> 26975371

The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.

Tong Sun1, Junjiang Fu2, Tao Shen1, Xia Lin3, Lan Liao1, Xin-Hua Feng4, Jianming Xu5.   

Abstract

Twist1 is a basic helix-loop-helix transcription factor that strongly promotes epithelial-to-mesenchymal transition, migration, invasion, and metastasis of cancer cells. The MAPK-phosphorylated Twist1 on its serine 68 (Ser(P)(68)-Twist1) has a significantly enhanced stability and function to drive cancer cell invasion and metastasis. However, the phosphatase that dephosphorylates Ser(P)(68)-Twist1 and destabilizes Twist1 has not been identified and characterized. In this study, we screened a serine/threonine phosphatase cDNA expression library in HEK293T cells with ectopically coexpressed Twist1. We found that the small C-terminal domain phosphatase 1 (SCP1) specifically dephosphorylates Ser(P)(68)-Twist1 in both cell-free reactions and living cells. SCP1 uses its amino acid residues 43-63 to interact with the N terminus of Twist1. Increased SCP1 expression in cells decreased Ser(P)(68)-Twist1 and total Twist1 proteins, whereas knockdown of SCP1 increased Ser(P)(68)-Twist1 and total Twist1 proteins. Furthermore, the levels of SCP1 are negatively correlated with Twist1 protein levels in several cancer cell lines. SCP1-dephosphorylated Twist1 undergoes fast degradation via the ubiquitin-proteasome pathway. Importantly, an increase in SCP1 expression in breast cancer cells with either endogenous or ectopically expressed Twist1 largely inhibits the Twist1-induced epithelial-to-mesenchymal transition phenotype and the migration and invasion capabilities of these cells. These results indicate that SCP1 is the phosphatase that counterregulates the MAPK-mediated phosphorylation of Ser(68)-Twist1. Thus, an increase in SCP1 expression and activity may be a useful strategy for eliminating the detrimental roles of Twist1 in cancer cells.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  breast cancer; cell signaling; epithelial-mesenchymal transition (EMT); gene regulation; molecular cell biology; protein interaction; protein phosphatase

Mesh:

Substances:

Year:  2016        PMID: 26975371      PMCID: PMC4882423          DOI: 10.1074/jbc.M116.721795

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

2.  Small CTD phosphatases function in silencing neuronal gene expression.

Authors:  Michele Yeo; Soo-Kyung Lee; Bora Lee; Esmeralda C Ruiz; Samuel L Pfaff; Gordon N Gill
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

Review 3.  PP2C family members play key roles in regulation of cell survival and apoptosis.

Authors:  Shinri Tamura; Shinnosuke Toriumi; Jun-Ichi Saito; Kenjiro Awano; Tada-Aki Kudo; Takayasu Kobayashi
Journal:  Cancer Sci       Date:  2006-07       Impact factor: 6.716

4.  Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.

Authors:  Katharine H Wrighton; Danielle Willis; Jianyin Long; Fang Liu; Xia Lin; Xin-Hua Feng
Journal:  J Biol Chem       Date:  2006-10-10       Impact factor: 5.157

Review 5.  Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.

Authors:  Qian Qin; Young Xu; Tao He; Chunlin Qin; Jianming Xu
Journal:  Cell Res       Date:  2011-08-30       Impact factor: 25.617

6.  PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage.

Authors:  A Vichalkovski; E Gresko; D Hess; D F Restuccia; B A Hemmings
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

7.  Twist1-induced invadopodia formation promotes tumor metastasis.

Authors:  Mark A Eckert; Thinzar M Lwin; Andrew T Chang; Jihoon Kim; Etienne Danis; Lucila Ohno-Machado; Jing Yang
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

8.  TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Authors:  Michele B Weiss; Ethan V Abel; Melanie M Mayberry; Kevin J Basile; Adam C Berger; Andrew E Aplin
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

9.  ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.

Authors:  Arindam Banerjee; Zheng-Sheng Wu; PengXu Qian; Jian Kang; Vijay Pandey; Dong-Xu Liu; Tao Zhu; Peter E Lobie
Journal:  Breast Cancer Res       Date:  2011-11-07       Impact factor: 6.466

10.  IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2.

Authors:  Ying-Wen Su; Tong-Xin Xie; Daisuke Sano; Jeffrey N Myers
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more
  12 in total

1.  ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Authors:  Wang Zeng; Shuchen Gu; Yi Yu; Yili Feng; Mu Xiao; Xin-Hua Feng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Expression signature of ten genes predicts the survival of patients with estrogen receptor positive-breast cancer that were treated with tamoxifen.

Authors:  He Huang; Qiyu Chen; Weijian Sun; Mingdong Lu; Yaojun Yu; Zhiqiang Zheng; Pihong Li
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

3.  Two-track virtual screening approach to identify both competitive and allosteric inhibitors of human small C-terminal domain phosphatase 1.

Authors:  Hwangseo Park; Hye Seon Lee; Bonsu Ku; Sang-Rae Lee; Seung Jun Kim
Journal:  J Comput Aided Mol Des       Date:  2017-06-26       Impact factor: 3.686

Review 4.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

Review 5.  Twist1: A Double-Edged Sword in Kidney Diseases.

Authors:  Jiafa Ren; Steven D Crowley
Journal:  Kidney Dis (Basel)       Date:  2020-01-17

6.  FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.

Authors:  Wells S Brown; Saeed Salehin Akhand; Michael K Wendt
Journal:  Oncotarget       Date:  2016-12-13

7.  Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer.

Authors:  George S Krasnov; Grigory A Puzanov; Marina A Afanasyeva; Erdem B Dashinimaev; Khava S Vishnyakova; Artemy D Beniaminov; Alexei A Adzhubei; Tatiana T Kondratieva; Yegor E Yegorov; Vera N Senchenko
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

Review 8.  AKT-ions with a TWIST between EMT and MET.

Authors:  Huifang Tang; Daniela Massi; Brian A Hemmings; Mario Mandalà; Zhengqiang Hu; Andreas Wicki; Gongda Xue
Journal:  Oncotarget       Date:  2016-09-20

Review 9.  Targeting the C-Terminal Domain Small Phosphatase 1.

Authors:  Harikrishna Reddy Rallabandi; Palanivel Ganesan; Young Jun Kim
Journal:  Life (Basel)       Date:  2020-05-08

10.  TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression.

Authors:  Svetlana A Mikheeva; Nathan D Camp; Lei Huang; Antrix Jain; Sung Yun Jung; Naze G Avci; Mari Tokita; Alejandro Wolf-Yadlin; Jing Zhang; Stephen J Tapscott; Robert C Rostomily; Andrei M Mikheev
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.